Efficacy and Safety of Almonertinib Combined With or Without Chemotherapy as an Adjuvant Treatment for Stage II-IIIA Non-small Cell Lung Carcinoma Following Complete Tumour Resection

Status:
Not yet recruiting

Trial end date:
2029-05-01

Target enrollment:

Participant gender:

This is a multicenter, randomized, open label, phase III study.

Phase 3

Chinese Academy of Medical Sciences

Jiangsu Hansoh Pharmaceutical Co., Ltd.

Cisplatin
Pemetrexed